Does RISANKIZUMAB-RZAA Cause Psoriasis? 6,896 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6,896 reports of Psoriasis have been filed in association with RISANKIZUMAB-RZAA. This represents 10.5% of all adverse event reports for RISANKIZUMAB-RZAA.
6,896
Reports of Psoriasis with RISANKIZUMAB-RZAA
10.5%
of all RISANKIZUMAB-RZAA reports
12
Deaths
778
Hospitalizations
How Dangerous Is Psoriasis From RISANKIZUMAB-RZAA?
Of the 6,896 reports, 12 (0.2%) resulted in death, 778 (11.3%) required hospitalization, and 11 (0.2%) were considered life-threatening.
Is Psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 6,896 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
Headache (1,554)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
DUPILUMAB (1,907)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Psoriasis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA